TapeVector

952 posts

TapeVector banner
TapeVector

TapeVector

@TapeVector

Researching companies, industries & charts with custom indicators. This is not financial advice.

Romania شامل ہوئے Ağustos 2020
432 فالونگ700 فالوورز
پن کیا گیا ٹویٹ
TapeVector
TapeVector@TapeVector·
I started investing with $20,000. This was all the money me and my wife saved in 10 years. My first stock was $LMT. I bought around $200. Price dropped. I got scared. I sold for around $10 loss. I thought this is not for me. A few weeks later I tried again. I bought $BABA. Same thing. In 2018, in Romania, I had a poor relationship with money. I did not understand risk. I did not understand volatility. I did not understand business quality. I did not understand market cycles. So I started reading. Warren Buffett. Benjamin Graham. The Intelligent Investor. Investing for Dummies. Every investing book I found. Then I started building my own system. A system for finding stocks. A system for reading charts. A system for buying weakness. A system for holding when the thesis is alive. A system for selling when the risk changes. I made bad decisions. $WYFI, bought $32, sold $18. $HIMS, bought $35, sold $20. $AUR, bought $6, sold $4. $MDAI, bought $2.30, sold $1.90. $ARBE, bought $2.20, sold $1.90. $IREN, bought $60, sold $51. I also sold too early. $NBIS at $150. $BABA at $135. $OKLO at $110. $ORCL at $125 before price went near $300. But I also found serious opportunities. $META at $101. $AMZN at $83 after split. $GOOGL at $85 after split. $COIN at $34. $MARA at $3.34. $MSTR at $135 before the 10 for 1 split. $NVDA at $139 before the 10 for 1 split. $PLTR at $21. $ARM at $101. $RKLB at $23. $TSM at $64. $AMD at $58. $BABA at $64. $NU at $3.70. $IONQ at $7.53. $OKLO at $17.90. My road was not clean. I lost money. I sold winners too early. I bought some wrong names. I got scared more than once. But the good decisions were bigger than the bad ones. Now my main account is up almost 300% in 5 years. I am still learning. I am still improving. I still make mistakes. This profile is where I will show how I think as an investor and swing trader. No fake certainty. No perfect record. No theory without skin in the game. Only process, charts, companies, entries, exits, mistakes, and lessons. I just want to share my ideas, my charts and my research.
TapeVector tweet mediaTapeVector tweet mediaTapeVector tweet mediaTapeVector tweet media
English
1
0
5
1.3K
TapeVector
TapeVector@TapeVector·
There are not many interesting tickers that pass me but @HunterAllen4 manages to surprise me from time to time. this is a good one bro. Nice $QXL
Hunter Allen@HunterAllen4

$QXL +19% Come on x fam hit that sub button to support this research 🤝 I’m finally settled at work, let the reply’s commence. Have a great Thursday. Love you guys, appreciate you all 🔥 Another quantum name quietly making moves while most traders are focused on the larger players. Quantum X Labs just announced the launch of an integrated quantum computing program combining its patent-pending CliniQuantum platform with its proprietary Quantum Error Correction (QECC) Decoder technology. This is a much bigger development than the headline suggests. The biggest challenge facing the entire quantum computing industry isn’t building more qubits. It’s making them reliable. Quantum computers are incredibly powerful but also extremely noisy and error-prone. That’s why error correction is considered one of the most important technologies needed to unlock true commercial quantum computing. $QXL is now integrating: • CliniQuantum clinical trial analysis platform • Proprietary QECC Decoder technology • Hybrid GPU + Quantum environments • Multiple quantum computing platforms The goal is simple: Improve computational fidelity and move closer to scalable fault-tolerant quantum applications. This positions $QXL as more than just another quantum hardware story. They’re building an end-to-end quantum ecosystem that combines hardware, software, AI, error correction, and real-world industry applications under a single platform. Most quantum companies are focused on one piece of the puzzle. $QXL is attempting to address the entire stack, from quantum processing and error mitigation to specialized algorithms designed for commercial use cases. One area that stands out is healthcare. Their CliniQuantum platform focuses on clinical trial optimization, predictive modeling, patient selection, and biomedical data analysis. Considering pharmaceutical companies spend billions annually on drug development and clinical trials, even small improvements in efficiency could create massive economic value. Recent developments continue to build momentum: • Launched 50+ qubit neutral atom quantum computer • Targeting thousands of qubits by H1 2027 • Recently partnered with IQCC and Quantum Machines for decoder testing • Expanded scientific and technical advisory teams • Now validating software and decoder performance across multiple quantum platforms The market opportunity here is enormous. If Quantum X can demonstrate measurable improvements in accuracy, speed, or trial optimization, it opens the door for: • Pharmaceutical partnerships • CRO partnerships • Government contracts • Software licensing revenue • Quantum-as-a-Service offerings What I want to see next: Benchmark results showing decoder performance improvements Named partnerships with pharma companies Commercial pilot programs Additional patent grants Progress toward the 2027 qubit roadmap Keep in mind this remains a high-risk, early-stage quantum company. Revenue impact from today’s announcement is likely minimal near term. Execution is everything. But the company continues checking important boxes and advancing toward a differentiated position in one of the highest-value use cases for quantum computing. $LASE $QTEX $APLD $NVDA $AAOI $UMC $QBTS $QUBT $IONQ $LITE $SIVE $ASYS $ADEA $RGTI $TE $BE Quantum sector momentum remains strong and $QXL continues to add catalysts. Definitely one to keep on watch.

English
3
0
5
137
Eltanin Capital
Eltanin Capital@eltanincapital·
$TRT Pick-and-shovel play on AI. Every advanced chip still needs reliability and burn-in testing before reaching customers. Exposure to packaging and back-end semis, areas benefiting from rising complexity in AI accelerators and high-performance computing. Southeast Asia manufacturing footprint (Singapore, Malaysia, Thailand, China), giving exposure to the ongoing diversification of semiconductor supply chains. Automotive + AI end markets, two segments requiring increasingly stringent testing standards. Tiny market cap relative to peers, meaning even moderate execution could have an outsized impact. Founder-led business with decades of semiconductor know-how. Indirect beneficiary of AI capex, without needing to predict which chip designer ultimately wins. $158mn mcap. $47.7mn 9M FY26 revenue (+85% YoY). Strong balance sheet to fund expansion, minimal debt. No position, just watching.
English
1
0
3
195
TapeVector
TapeVector@TapeVector·
I just published my full research report on $TRT. My investing journal, not financial advice. Trio-Tech International is not a fake AI story. The company has real semiconductor reliability testing exposure. Real AI GPU burn in board orders. Real final test services for AI chips. Real automotive semiconductor burn in exposure. But the report is not a hype piece. The main conclusion is simple: The revenue opportunity is real. The economics are not proven yet. That matters because $TRT is growing fast, but gross margin compressed sharply. Customer concentration is high. Customer names are undisclosed. Order repeatability is still unproven. Malaysia capacity is real, but utilization is not proven yet. So for me, this is not a proven compounder. Not yet. It is a contract conversion story. A future capacity story. A trade only classification for now. I know @HunterAllen4 and @JonkooTrades have interest in the stock and in this research, so this report is also for anyone trying to separate the real proof from the market story. Final read: Real business. Real AI and auto semiconductor exposure. Fragile economics. Needs more proof. Evidence first. Margins second. Customer proof next.
TapeVector tweet media
TapeVector@TapeVector

x.com/i/article/2067…

English
4
1
12
1.5K
TapeVector
TapeVector@TapeVector·
Credit to @RosannaInvests for flagging this $EOSE update. My investing journal, not financial advice. This is the kind of update that matters. Not because it sounds exciting. Because it shows conversion. A reservation turning into a real purchase order is different from a pipeline slide. The Redbird project is now a firm order. 100 MW / 400 MWh. Texas. ERCOT grid. Z3 zinc battery technology. That means $EOSE is not only talking about grid storage demand. It is starting to convert signed interest into real project activity. That is the good part. The better part is the structure of the thesis. Grid demand needs storage. Texas needs flexible capacity. Solar and wind need dispatchable support. Long duration storage has a real use case. Non lithium chemistry gives $EOSE a different angle. But I still want to separate story from proof. What is proven: Reservation converted into a PO. A real project moved forward. Z3 is getting commercial validation. Backlog conversion is happening. What is not proven yet: Delivery execution. Margin quality. Cash conversion. Repeat order cadence. Balance sheet pressure. Scaling without dilution. So this is a good update. But not a blind chase signal for me. The thesis improves when backlog turns into revenue, revenue turns into gross profit, and gross profit turns into cash. That is the next proof layer. For me, $EOSE is a real grid storage watchlist name. The story is getting better. Now execution has to catch up. Evidence first. Margins second. Cash conversion last.
TapeVector tweet mediaTapeVector tweet mediaTapeVector tweet mediaTapeVector tweet media
Rosanna Prestia, MBA@RosannaInvests

$EOSE just turned a reservation into a real order. 👏 First PO under the 2 GWh Frontier Power USA agreement → the Redbird project, 100 MW / 400 MWh, four-hour storage for ERCOT, on Eos Z3 tech. Why it matters: this is the model working → developer relationships becoming committed capital becoming deployed assets. With this order EOSE has filled nearly 50% of the 1 GWh Bridgelink MSA, and there’s a 12 GWh pipeline behind it across ERCOT, PJM, CAISO and MISO. American-made, non-lithium, long-duration storage for a grid that needs four-hour dispatchable power now. The backlog is converting. 💪 Long $EOSE

English
0
0
3
236
Hunter Allen
Hunter Allen@HunterAllen4·
@TapeVector I do not sir I know of her but haven’t done a dd on her or $CVV even tho I’m bullish
English
1
0
1
16
Hunter Allen
Hunter Allen@HunterAllen4·
These are all semi & memory stocks I think we’re still relatively early on. Yes they are up but market cap wise just taking off. Yes I have posted dd on like 10 of these. $INTT $ASYS $COHU $NSYS $TRT $VECO $ADEA $AOSL $MRAM $POET $SILC $CEVA $QUIK $AIP $GSIT $CVV $MX
English
4
3
18
1.3K
TapeVector
TapeVector@TapeVector·
@asianinvestors not interesting in promoting, just interesting in sharing and learning. Thanks because your open.
English
0
0
0
2
The Asian Investor
The Asian Investor@asianinvestors·
$TRT is gaining so much attention on X today, probably because it's up 60% in the past week. So quick recap on the thesis: They're a back end testing company riding on two massive demand waves in chips. AI GPUs and EV power devices. They test chips before they ship, essentially being the quality gate for mission critical silicon. They've won burn in board orders worth 8M for nexty gen AI GPU platforms and landed a 2.5M production order from an automotive IDM. They're also expanding capacity across Malaysia with a new facility in Penang due to the growth in testing demand in South East Asia. So whats the theme? As AI and EV chips get more complex and reliability is critical, outsourced back end testing demand will inevitably grow, and TRT is one of the few pure play small caps with reliable customer wins already
The Asian Investor@asianinvestors

After doing a bit of DD, I have just initiated a small position on $TRT pre market. Thesis is strong, but still a speculative buy. I'll be digging into it deeper this week. Trading about 2.5x P/S, 140M MC Revenue growth accelerating rapidly. And I don't have any positions in OSAT sector. Only about 2% of port. I heard about it from @athuinvests so check his page out for full thesis

English
1
0
7
1.4K
TapeVector
TapeVector@TapeVector·
@KorayChelikhan @HunterAllen4 it's just me, I'm not here to get praises I am here to learn and inform others on what I know. But there is always stuff to learn from everybody, so I am very open to say I don't know. Thanks for nodicing.
English
0
0
2
10
Gublo
Gublo@Gubloinvestor·
If $MU hits $2000 It will be $2T plus market cap..
English
31
2
120
12K
TapeVector
TapeVector@TapeVector·
This is a great read on $COHU . I recommend it. I like it because it looks past the obvious AI names. Everyone talks about GPUs. Fewer people ask: Who tests them? Who manages the heat? Who checks yield? Who inspects the memory stack? Who keeps the production line moving? That is where the better supply-chain work starts. $COHU is interesting because the market still treats it like a cyclical semiconductor equipment name. But the business is getting exposure to: HPC processors. HBM inspection. GaN power devices. Advanced packaging. Thermal test systems. AI-powered yield optimization. Recurring consumables and services. That does not make it an automatic buy. Price still matters. Execution still matters. Cyclicality still matters. But the framework is right. The AI trade is not only $NVDA . The better question is: Which companies sit underneath the AI supply chain and become more important as the chips become harder to make? Good work by @HunterAllen4 This is the type of research angle I respect. My investing journal, not financial advice.
Hunter Allen@HunterAllen4

$COHU +5% yesterday. Testing 26-year highs. DONT MISS X FAM Everyone talks about GPUs. Almost nobody talks about the companies making sure those GPUs actually work. $AEHR $TER $AMKR $FORM all getting attention in silicon testing bottleneck. Cohu ($COHU) sits in one of the most overlooked bottlenecks in semiconductors: testing, thermal management, inspection, and yield optimization. Some things that stood out: • Top-3 global semiconductor test handler provider with ~20-28% share of a $2.1B market. • Global leader in RF power amplifier testing used in 5G and automotive systems. • Roughly 14% share of the global test contactor/socket market. • ~60% of revenue comes from recurring sources including consumables, spares, services, software, and maintenance. Q1 2026: • Revenue: $125.1M (+29% YoY) • Orders: +57% YoY • Test handler orders: +54% • Inspection/metrology orders: +64% • Cash & investments: $489M Management raised FY26 growth outlook to 20-25%. The AI story is getting bigger too. Cohu increased expected HPC revenue to $80M-$100M in 2026 and expanded its AI/HPC addressable market estimate to roughly $750M. That’s a massive jump from prior expectations of just $25M-$30M. Why? Their Eclipse platform is designed for next-generation AI processors that generate enormous amounts of heat during testing. Their T-Core thermal systems provide the precision temperature control needed for AI accelerators, GPUs, and HPC processors where thermal issues directly impact yields. In May, they secured major Diamondx platform orders tied to Gallium Nitride (GaN) power devices being deployed throughout AI data center power infrastructure. Another overlooked catalyst: In 2025 they acquired Tignis for $40M. Tignis brings AI-powered digital twins, predictive maintenance, machine learning analytics, and yield optimization software that is now integrated into Cohu’s DI-Core platform. Instead of simply testing chips, they’re increasingly using AI to predict failures before they happen. This gives them exposure to both semiconductor equipment and semiconductor software. Meanwhile HBM demand continues ramping. Their NEON inspection platform is positioned around HBM3 and HBM4 production with AI-powered optical inspection, metrology, and yield analytics. The market still largely views COHU as a cyclical semiconductor equipment company. But the business is increasingly becoming an AI infrastructure enabler with exposure to HPC processors, HBM memory, GaN power systems, advanced packaging, factory AI software, and high-margin recurring revenue. Everyone knows $NVDA. Few are looking at the companies that test the chips, manage the thermals, inspect the memory stacks, optimize yields, and keep production moving. That’s where $COHU plays. A picks-and-shovels AI infrastructure name sitting underneath the semiconductor supply chain. $MRVL $ICHR $VECO $AMD $AAOI $POET $MU $AVGO $ONTO $LITE If management executes, the valuation gap between how the market views COHU and what the business is becoming may be the opportunity.

English
2
1
2
583
TapeVector
TapeVector@TapeVector·
@HunterAllen4 thanks when it is totally ready I will write an explanation on how to read the indicators and what are the best setups in probabilities.
English
0
0
1
4
TapeVector
TapeVector@TapeVector·
$SOFI rejected the 3rd try to pass the resistance, can we tray a 4th time? the 2D chart looks like it wants to try again. On the weekly the the ribbon is starting narrow, maybe if ewe brake the resistance on the 1D, and we close inside the ribbon on the 1W we could see a reversal. If not then we will move through the channel $20-$15 until something brakes.
TapeVector tweet mediaTapeVector tweet mediaTapeVector tweet media
TapeVector@TapeVector

$SOFI at a key level, will it break or maybe it will go back and make an double top and then go lower. Nobody knows, maybe just the CEO. $FINX

English
1
0
3
377
TapeVector
TapeVector@TapeVector·
@HunterAllen4 I like $RUM on the 1W chartt, but on the short term it needs to repair imho, kind of like $TRT , on Monday it looked primed so it ripped from 12 to 17.5 today. and $BTQ I would love in the low $4, I will 👀
English
0
0
2
188
Hunter Allen
Hunter Allen@HunterAllen4·
GM X FAM 🔥 Don’t miss these. Three very slept on stocks. $TRT $BTQ $RUM
Hunter Allen tweet mediaHunter Allen tweet mediaHunter Allen tweet media
English
48
8
80
6.9K
TapeVector
TapeVector@TapeVector·
@fundmyfund I was waiting for a bakeout also but nah maybe next week
TapeVector tweet media
English
1
0
0
12
TapeVector
TapeVector@TapeVector·
@HunterAllen4 did not enter because I did not like the last daily candle. I am sorry now I did not listen to my instinct and I listened to the chart. It is what it is. 🤷‍♂️
TapeVector tweet media
English
1
0
1
19
Hunter Allen
Hunter Allen@HunterAllen4·
$BFLY +22% PRE-MARKET Previously mentioned a couple weeks ago on breakout. One of the more interesting AI healthcare stories in the market right now. Butterfly Network ($BFLY) is the leader in handheld ultrasound technology through its proprietary Ultrasound-on-Chip platform, replacing traditional ultrasound hardware with semiconductor-based imaging. Today’s catalyst: Butterfly provided commentary on Midjourney Medical’s new full-body ultrasound scanner prototype. The scanner utilizes 40 Butterfly Ultrasound-on-Chip imaging modules under an existing licensing/co-development agreement announced in November 2025. That agreement alone carries up to $74M in potential payments over five years. This is a major validation of Butterfly’s growing “Embedded” business segment. The bigger picture: Midjourney’s scanner combines: • 40x Butterfly imaging modules • Massive AI reconstruction software • NVIDIA-powered compute infrastructure The system reportedly processes enormous data volumes, utilizing multiple servers and AI models to generate MRI-like imaging without radiation. $NVDA benefits as the compute backbone while $BFLY supplies the core imaging technology. Financially, $BFLY continues improving: • FY26 Revenue Guidance: $117M-$121M • Expected YoY growth: 20-24% • Q1 Revenue: ~$26.5M • Q2 Revenue Guidance: $27M-$31M Balance sheet remains one of the strongest among small-cap medical device names: • ~$140M Cash • $0 Debt • LTM Free Cash Flow: approximately -$20M At current burn rates, that’s roughly 7 years of runway. No immediate financing concerns. Another catalyst investors may be overlooking: Management has already disclosed plans for a next-generation probe launching in early 2027. Specs and pricing are expected to be released in late 2026. The new system will introduce tissue harmonic imaging, improving image quality and extending Butterfly’s technological lead versus competing handheld ultrasound platforms. Today at 12 PM ET, management is participating in TD Cowen’s Medical Devices Emerging Growth Call Series. Investors will be listening closely for updates on: • Enterprise adoption • AI subscription growth • Embedded licensing revenue • Midjourney partnership progress • Commercialization roadmap The Midjourney scanner itself remains early-stage and faces regulatory hurdles, but Butterfly wins regardless through licensing revenue and broader adoption of its semiconductor ultrasound platform. Market Cap: ~$1.5B Strong balance sheet. Growing recurring software revenue. Embedded licensing opportunities. AI healthcare exposure. Potential NVIDIA ecosystem connection. Definitely one to keep on watch. My subscription is $1/month. Let’s keep growing x fam. You’re not paying for buy/sell alerts — you’re supporting the time and research it takes to consistently find overlooked opportunities 99% of X don’t share. And more accounts to follow. Like these legends. @Wealth_WZRD @UnotheInvestor @cdettradess @M1CPW @InvestwithDoc @brandon_Invests @dusty_bull @kastriooot8 @Vance_Roberts5 @wallstnomads @QHCapital @CryptoSlider @Digital_Hus @Twills08 @notanotherquant @KeepitPassive @Jetson_Dad @PMooreTrades @gulVasikova @ZeekTyt @Btcbarbells @TheBTCKnight @ItsJamesHall @FinancePotentia @TapeVector @TrackNetWorth @ElijahColeman21 @LeifInvests @Options_Nirvana @investing_note @AfterHours1999 @couchpotradeo @leftlaneinvest @Noamneo_ @ThePoliteG @tradeconciencia @KieranT1000 @jonesrrrrrr @alecscrypto1 Most content will always stay free. Subscribers help me spend more time digging deeper, organizing ideas, and expanding research output.
Hunter Allen tweet media
English
19
9
63
3.5K